European Pharmaceutical Review

OCTOBER 18, 2022

billion by 2030, according to a market report. However, during the second half, the surge in demand for vaccines to fight the coronavirus enhanced the industry’s need for raw materials and product intermediates of API molecules. billion by 2030 appeared first on European Pharmaceutical Review. billion in 2022 to $14.65

Dosage 94

Dosage Vaccines 94

European Pharmaceutical Review

SEPTEMBER 7, 2022

The second most commonly used pharmaceutical dosage form, capsules, are anticipated to be a $5.2 billion market by 2030, growing from a 2020 value of around $2.4 Compared with other oral solid dosage forms (OSDs), capsules also offer the easiest method to achieve fixed-dose combinations (FDCs) of incompatible drug substances.

Dosage 121

Dosage Vaccines 121

ISPE

SEPTEMBER 11, 2023

POD is suitable for a wide range of products, including oral solid dosage forms, mAbs, and cell therapy. Worldwide Modular Facilities in Pharmaceutical and Biotechnology Industry to 2030 - Impact Analysis of COVID-19.” Sanofi Pumps $554M into New Vaccine Manufacturing Facility in Eastern France.” 13 July 2021. 16 June 2020.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52